Oppenheimer Asset Management Inc. bought a new position in shares of Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,870 shares of the technology company’s stock, valued at approximately $682,000.
Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Celestica by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 4,811,695 shares of the technology company’s stock worth $1,423,333,000 after acquiring an additional 73,022 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in Celestica by 24.8% in the fourth quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company’s stock worth $1,187,650,000 after purchasing an additional 798,782 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in Celestica by 5,806,149.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company’s stock worth $1,081,323,000 after purchasing an additional 3,657,874 shares during the period. Franklin Resources Inc. boosted its position in shares of Celestica by 18.6% during the fourth quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company’s stock worth $673,471,000 after purchasing an additional 356,797 shares in the last quarter. Finally, Cibc World Market Inc. boosted its position in shares of Celestica by 30.6% during the fourth quarter. Cibc World Market Inc. now owns 2,265,680 shares of the technology company’s stock worth $670,279,000 after purchasing an additional 530,535 shares in the last quarter. 67.38% of the stock is currently owned by institutional investors and hedge funds.
Celestica Trading Up 1.2%
CLS opened at $339.20 on Tuesday. The stock has a market capitalization of $39.00 billion, a P/E ratio of 35.26 and a beta of 2.06. The company has a current ratio of 1.23, a quick ratio of 0.68 and a debt-to-equity ratio of 0.32. Celestica, Inc. has a 12 month low of $173.23 and a 12 month high of $474.02. The firm’s fifty day simple moving average is $347.21 and its 200 day simple moving average is $335.51.
Analysts Set New Price Targets
A number of analysts recently commented on the stock. JPMorgan Chase & Co. upped their price objective on shares of Celestica from $445.00 to $485.00 and gave the company an “overweight” rating in a research report on Wednesday, July 29th. Citigroup boosted their target price on Celestica from $338.00 to $415.00 and gave the company a “buy” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada increased their price target on Celestica from $440.00 to $450.00 and gave the stock an “outperform” rating in a report on Wednesday, July 29th. Barclays dropped their price target on Celestica from $430.00 to $406.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Finally, Stifel Nicolaus set a $500.00 price objective on Celestica in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Celestica presently has a consensus rating of “Moderate Buy” and an average price target of $438.86.
View Our Latest Stock Report on Celestica
Insider Transactions at Celestica
In related news, CFO Mandeep Chawla sold 17,000 shares of Celestica stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $399.65, for a total value of $6,794,050.00. Following the sale, the chief financial officer owned 82,444 shares of the company’s stock, valued at approximately $32,948,744.60. This trade represents a 17.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Robert Mionis sold 98,453 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total value of $36,328,172.47. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 356,553 shares of company stock valued at $135,238,444. 1.10% of the stock is owned by corporate insiders.
Celestica Company Profile
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Featured Stories
- Five stocks we like better than Celestica
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
